Prescient raises $9.8m to drive cancer therapies
Prescient has topped up its $6.9 million SPP with a $3 million placement to accelerate its oncology pipeline.
Prescient has topped up its $6.9 million SPP with a $3 million placement to accelerate its oncology pipeline.
Control Bionics, Alterity Therapeutics and Neurotech International are among ASX health companies reporting quarterly results this week.
Harvest Technology Group recorded a 135% YoY increase in quarterly revenue, reaching $1.1 million in Q4 FY25.
Ramelius Resources completes the acquisition of Spartan Resources gaining access to millions of gold ounces.
The ASX found some momentum in the energy sector today, rising 0.08pc despite general anxieties over US tariff impacts.
Resolution Minerals has enlisted two Trump-affiliated firms to back its Horse Heaven antimony-tungsten project in proposed Nasdaq listing
EMVision has received ethics approval for two studies that will advance prototype First Responder scanner toward commercial production.
St George Mining has delivered a 30kg bulk sample from its Araxa project to a Brazilian government-backed supply chain program.
Aroa Biosurgery recorded its third consecutive quarter of positive net cash flow since listing on the ASX in July 2020 and has reaffirmed FY26 revenue guidance.
DY6 Metals has kicked off a soil sampling program to guide maiden auger drilling at its Central rutile project in Cameroon.
European pharma companies are breathing a sigh of relief after the Trump administration posed a 15pc tariff, rather than 200pc.
A study has upgraded the prospective resource at Pancontinental Energy’s Oryx prospect by 53% to 815MMbbl while boosting success odds to 26.2%.
Loyal Metals is using modern exploration including a high-tech geophysics drone survey to identify new copper-gold targets.
Victory Metals has produced a high-value, mixed rare earth oxide at its North Stanmore project in Western Australia.
Original URL: https://www.thechronicle.com.au/business/stockhead/page/8